The risk of cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention
S. Singla, R. Sachdeva, B.F. Uretsky The risk of cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention J Am Coll Cardiol 60 2012 2005 2016
Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies
A.J. Kirtane, A. Gupta, S. Lyengar Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI)
W. Wijns, P. Kolh, N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 2501 2555
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Society for Cardiovascular Angiography and Interventions
American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular and Angiography Interventions
G.N. Levine, E.R. Bates, J.C. Blankenship American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular and Angiography Interventions 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial
M. Valgimigli, G. Campo, M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
A new strategy for discontinuation of dual antiplatelet therapy: The RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
B.K. Kim, M.K. Hong, D.H. Shin A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348